warrenhochfeld

Heron Therapeutics Bull Run

NASDAQ:HRTX   Heron Therapeutics, Inc.
Start of a bull run on Heron Therapeutics.
Initial catalyst: PDUFA review of Cinvanti 11 November 2017
Secondary catalyst: Fast track designation for HTX-011
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.